LATOSHA FOSTER: Open Payments
NPI 1952914731 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$186 in 9 payments from 6 companies in 2025. Trend: 2023 $82 · 2024 $167 · 2025 $186
Food & beverage: $186
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $44 |
| SCPHARMACEUTICALS INC. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Philips North America LLC | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| BridgeBio Pharma, Inc. | 1 | $15 |
Products named: REPATHA, FUROSCIX, LEQVIO, Ambulatory Monitoring & Diagnostics Undivided, Attruby.
Industry payments across VA — which companies pay providers there.
